ENZO BIOCHEM INC Quarterly Operating Margin in % from Q2 2011 to Q3 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Enzo Biochem Inc quarterly/annual Operating Margin history and growth rate from Q2 2011 to Q3 2024.
  • Enzo Biochem Inc Operating Margin for the quarter ending October 31, 2024 was -34.7 %, a 57% increase year-over-year.
  • Enzo Biochem Inc annual Operating Margin for 2024 was -38.8 %, a 51.3% increase from 2023.
  • Enzo Biochem Inc annual Operating Margin for 2023 was -79.6 %, a 52.7% decline from 2022.
  • Enzo Biochem Inc annual Operating Margin for 2022 was -52.2 %, a 8974% decline from 2021.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -34.7 +45.9 +57% Aug 1, 2024 Oct 31, 2024
Q2 2024 -38.8 +40.9 +51.3% May 1, 2024 Jul 31, 2024
Q1 2024 -50.7 -137 -159% Feb 1, 2024 Apr 30, 2024
Q4 2023 -70.8 -240 -142% Nov 1, 2023 Jan 31, 2024
Q3 2023 -80.5 +69.3 +46.3% Aug 1, 2023 Oct 31, 2023
Q2 2023 -79.6 -27.5 -52.7% May 1, 2023 Jul 31, 2023
Q1 2023 86.3 +95.7 Feb 1, 2023 Apr 30, 2023
Q4 2022 169 +173 Nov 1, 2022 Jan 31, 2023
Q3 2022 -150 -148 -10483% Aug 1, 2022 Oct 31, 2022
Q2 2022 -52.2 -52.8 -8974% May 1, 2022 Jul 31, 2022
Q1 2022 -9.38 -9.24 -6618% Feb 1, 2022 Apr 30, 2022
Q4 2021 -4.46 +7.92 +64% Nov 1, 2021 Jan 31, 2022
Q3 2021 -1.42 +24.2 +94.5% Aug 1, 2021 Oct 31, 2021
Q2 2021 0.59 +40.5 May 1, 2021 Jul 31, 2021
Q1 2021 -0.14 Feb 1, 2021 Apr 30, 2021
Q4 2020 -12.4 Nov 1, 2020 Jan 31, 2021
Q3 2020 -25.7 Aug 1, 2020 Oct 31, 2020
Q2 2020 -40 May 1, 2020 Jul 31, 2020
Q1 2019 2.03 +8.61 Feb 1, 2019 Apr 30, 2019
Q4 2018 -26.4 -22.3 -541% Nov 1, 2018 Jan 31, 2019
Q3 2018 -18.4 -16 -693% Aug 1, 2018 Oct 31, 2018
Q2 2018 -12 -9.12 -312% May 1, 2018 Jul 31, 2018
Q1 2018 -6.58 -39.2 -120% Feb 1, 2018 Apr 30, 2018
Q4 2017 -4.12 -34.8 -113% Nov 1, 2017 Jan 31, 2018
Q3 2017 -2.31 -41.7 -106% Aug 1, 2017 Oct 31, 2017
Q2 2017 -2.92 -48.5 -106% May 1, 2017 Jul 31, 2017
Q1 2017 32.6 +14.8 +82.8% Feb 1, 2017 Apr 30, 2017
Q4 2016 30.7 +12.7 +70.9% Nov 1, 2016 Jan 31, 2017
Q3 2016 39.4 +32.8 +492% Aug 1, 2016 Oct 31, 2016
Q2 2016 45.6 +46.8 May 1, 2016 Jul 31, 2016
Q1 2016 17.9 +31.1 Feb 1, 2016 Apr 30, 2016
Q4 2015 18 +28.9 Nov 1, 2015 Jan 31, 2016
Q3 2015 6.65 +17.3 Aug 1, 2015 Oct 31, 2015
Q2 2015 -1.24 +9.37 +88.3% May 1, 2015 Jul 31, 2015
Q1 2015 -13.3 -2.13 -19.1% Feb 1, 2015 Apr 30, 2015
Q4 2014 -10.9 +5.84 +34.8% Nov 1, 2014 Jan 31, 2015
Q3 2014 -10.6 +8.94 +45.8% Aug 1, 2014 Oct 31, 2014
Q2 2014 -10.6 +9.64 +47.6% May 1, 2014 Jul 31, 2014
Q1 2014 -11.2 +34.7 +75.7% Feb 1, 2014 Apr 30, 2014
Q4 2013 -16.8 +25.5 +60.3% Nov 1, 2013 Jan 31, 2014
Q3 2013 -19.5 +19.4 +49.8% Aug 1, 2013 Oct 31, 2013
Q2 2013 -20.3 +19 +48.4% May 1, 2013 Jul 31, 2013
Q1 2013 -45.8 -30.7 -202% Feb 1, 2013 Apr 30, 2013
Q4 2012 -42.2 -28.2 -202% Nov 1, 2012 Jan 31, 2013
Q3 2012 -39 -23.1 -145% Aug 1, 2012 Oct 31, 2012
Q2 2012 -39.3 -26.6 -210% May 1, 2012 Jul 31, 2012
Q1 2012 -15.2 Feb 1, 2012 Apr 30, 2012
Q4 2011 -14 Nov 1, 2011 Jan 31, 2012
Q3 2011 -15.9 Aug 1, 2011 Oct 31, 2011
Q2 2011 -12.7 May 1, 2011 Jul 31, 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.